Kisspeptin Research for Hypoactive Sexual Desire Disorder
An evidence-based overview of research examining Kisspeptin in the context of hypoactive sexual desire disorder. This page synthesizes findings from peer-reviewed literature.
Research Summary
fMRI studies show kisspeptin enhances limbic brain activity to sexual stimuli in men. RCTs demonstrated enhanced brain responses to sexual content and improved penile tumescence in men with HSDD. This represents an emerging application beyond reproductive function.
Referenced Studies
Click any PMID to view the full study on PubMed.
Other Peptides Studied for Hypoactive Sexual Desire Disorder
Important Disclaimer
This page summarizes research findings and does not constitute medical advice. Kisspeptin may have regulatory approval for some indications but should only be used under qualified medical supervision. Always consult a healthcare provider before making health decisions.